Article
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19.
Translational research : the journal of laboratory and clinical medicine - 1 Jun 2022
Nln Ilona, Fernandez-Ruiz Ruth, Muskardin Theresa L Wampler, Paredes Jacqueline L, Blazer Ashira D, Tuminello Stephanie, Attur Mukundan, Iturrate Eduardo, Petrilli Christopher M, Abramson Steven B, Chakravarti Aravinda, Niewold Timothy B
Abstract excerpt
Type I interferon (IFN) is critical in our defense against viral infections. Increased type I IFN pathway activation is a genetic risk factor for systemic lupus erythematosus (SLE), and a number of common risk alleles contribute to the high IFN trait. We hypothesized that these common gain-of-function IFN pathway alleles may be associated with protection from mortality in acute COVID-19. We studied patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
